Saturday, April 22, 2017 4:20:15 PM
If folks think these gents are sitting around picking their noses bored waiting for the next results on Voclosporin. you are greatly mistaken.
So the AUPH Board of Directors is dripping with Merger and Acquisition talent. lets review as its pretty hilarious how obvious this company is for sale
We all know the first--> Richard Glickman. He needs no introduction for folks like us who listen into the webcasts. This dude knows the business and is well aware of the position he has the company in at this point. Former Founder and CEO of Aspreva Pharma who developed CellCept- the current standard of care for Lupus Nephritis. Aspreva Pharma was acquired by Galenica in 2008.
We have Lorin "Jeff" Randall with over 30 years experiences with biotech financials, he has "led a number of companies through multi-million dollar financings, mergers and acquisitions
There's Gregory Ayers MD PhD who was a venture partner for MPM Capital when he founded CryoCor (NASDAQNM:CRYO)...CryoCor was bought by Boston Scientific in 2007. He served on the Board of Hemosense which was bought by Inverness Medical and prior to all of this he was VP of clinical affairs for INcontrol which was bought by Guidant in the late 90's.
Don't forget Dr David Jayne who appears to be a world authority on all things lupus as well as a medical advisor to the UK, US, and EU Regulatory Bodies from a certified nephrology standpoint...
Then we have the final two recent appointments which are really exciting! lets see...
There's Hyuek Joon Lee Phd- this dude knows what he is doing for sure. Currently he is Director of New Business Development for ILJIN group. (we know who they are!) For ILJIN he is "responsible for mergers and acquisitions and managing overseas investments, joint ventures and subsidiaries."
Finally we have Ben Rovinski Phd. He's one of my favorites. why? well he is an ole chap from Lumira Capital. (we know who they are). Glick is a partner at Lumira as well. Ben has an investment focus on mid-to-late stage life science companies. "His current and past board roles and investment responsibilities include several companies, including KAI Pharma (acquired by AMGEN); Morphotek (acquired by Eisai); Health Hero Network (acquired by Bosch); Avalon Pharma (acquired by Clinical Data inc); SGX Pharma (acquired by Eli Lilly). among other companies. this guy has made deals after deals after deals after deals
When you doubt your investment just re-read my synopsis here and ask yourself how many times I had to type " bought by" or "acquired by"
I can tell you this, this Board was assembled for a reason folks
Recent AUPH News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/20/2024 08:56:55 PM
- Aurinia to Participate in 2024 Cantor Fitzgerald Global Healthcare Conference • Business Wire • 09/13/2024 10:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/12/2024 08:08:25 PM
- Aurinia Announces Board Restructuring • Business Wire • 09/12/2024 08:05:00 PM
- Aurinia Announces First Participant Dosed in AUR200 Single Ascending Dose Trial • Business Wire • 09/05/2024 10:00:00 AM
- Aurinia to Participate in H.C. Wainwright 26th Annual Global Investment Conference • Business Wire • 08/28/2024 10:00:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/08/2024 08:06:59 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/01/2024 10:07:59 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/01/2024 10:03:38 AM
- Aurinia Pharmaceuticals Reports Second Quarter and Six Months 2024 Financial and Operational Results • Business Wire • 08/01/2024 10:00:00 AM
- Aurinia Pharmaceuticals to Release Second Quarter Financial and Operational Results on August 1, 2024 • Business Wire • 07/19/2024 10:00:00 AM
- Aurinia to Participate in Upcoming Investor Healthcare Conferences • Business Wire • 07/02/2024 10:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/14/2024 09:25:28 PM
- Aurinia Announces 2024 Annual General Meeting Results • Business Wire • 06/14/2024 04:16:00 PM
- Aurinia Presents Safety and Efficacy Profile of LUPKYNIS® for People with Lupus Nephritis at European Alliance of Associations for Rheumatology (EULAR) Congress 2024 • Business Wire • 06/05/2024 10:00:00 AM
- Aurinia Addresses Dubious Proposals Put Forth by Lucien Selce • Business Wire • 06/04/2024 09:30:00 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 06/04/2024 09:25:39 PM
- Aurinia Provides Update on Proxy Statement • Business Wire • 06/03/2024 10:30:00 PM
- Aurinia Will Attend 2024 Jefferies Global Healthcare Conference • Business Wire • 05/30/2024 10:00:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/22/2024 08:16:53 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/22/2024 08:14:25 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/22/2024 08:11:31 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/22/2024 08:09:46 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/22/2024 08:07:15 PM
- Analysis Showing LUPKYNIS® is a Cost-Effective Treatment for Lupus Nephritis Presented at National Kidney Foundation’s Spring Clinical Meeting 2024 • Business Wire • 05/14/2024 10:00:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM